Rhythm Pharma shares rise after Phase 3 data show strong BMI drop. FDA decision on obesity drug due by March 20.
Why Is Rhythm Pharmaceuticals Stock Trading Higher Today?
Rhythm Pharma shares rise after Phase 3 data show strong BMI drop. FDA decision on obesity drug due by March 20.